Expression and function of androgen receptor coactivators in prostate cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 4, 2004, Pages 265-271

  Culig, Zoran ^a   Comuzzi, Barbara ^a   Steiner, Hannes ^a   Bartsch, Georg ^a   Hobisch, Alfred ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b General Hospital Feldkirch   (Austria)

Author keywords

Androgen ablation; Androgen receptor; Coactivator; Prostate cancer; Protein protein interaction

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; COMPLEMENTARY DNA; HYDROXYFLUTAMIDE; INTERLEUKIN 6; MESSENGER RNA; NUCLEAR RECEPTOR COACTIVATOR 2; PRASTERONE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P300; PROTEIN SUBUNIT; RAC PROTEIN; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1;

CANCER CELL; CANCER GRADING; CANCER STAGING; GENETIC TRANSFECTION; HORMONAL THERAPY; HUMAN; LABORATORY; LIGAND BINDING; LYMPH NODE; LYMPH NODE METASTASIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE SECTION; TUMOR CELL LINE; UPREGULATION;

EID: 12344338583     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.10.003     Document Type: Article

References (55)

1. C.A. Heinlein, and C. Chang Androgen receptor (AR) coregulators: an overview Endocrine Rev. 23 2002 175 200
2. K. Hofman, J.V. Swinnen, G. Verhoeven, and W. Heyns E2F activity is biphasically regulated by androgens in LNCaP cells Biochem. Biophys. Res. Commun. 283 2001 97 101
3. F.J. Dilworth, and P. Chambon Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate interaction of transcription Oncogene 20 2001 3047 3054
4. Z. Culig, H. Klocker, G. Bartsch, and A. Hobisch Mutations of androgen receptor in carcinoma of the prostate - significance for endocrine therapy Am. J. Pharmacogenom. 1 2001 241 249
5. C. Nessler-Menardi, I. Jotova, Z. Culig, I.E. Eder, T. Putz, G. Bartsch, and H. Klocker Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models Prostate 45 2000 124 131
6. C.L. Smith, Z. Navaz, and B.W. O'Malley Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen Mol. Endocrinol. 11 1997 657 666
7. C.W. Gregory, B. He, R.T. Johnson, O.H. Ford, J.L. Mohler, F.S. French, and E.M. Wilson A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy Cancer Res. 61 2001 4315 4319
8. L.V. Nazareth, D.L. Stenoien, W.E. Bingman 3rd, A.J. James, C. Wu, Y. Zhang, D.P. Edvards, M. Mancini, M. Marcelli, D.J. Lamb, and N.L. Weigel A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 Mol. Endocrinol. 13 1999 2065 2075
9. V.J. Gnanapragasam, H.Y. Leung, A.S. Pulimood, D.E. Neal, and C.E. Robson Expression of RAC3, a steroid hormone receptor co-activator in prostate cancer Br. J. Cancer 85 2001 1928 1936
10. G. Zhou, Y. Hashimoto, I. Kwak, S.Y. Tsai, and M.J. Tsai Role of the steroid receptor coactivator SRC-3 in cell growth Mol. Cell. Biol. 23 2003 7742 7755
11. K. Fronsdal, N. Engedal, T. Hagsvold, and F. Saatcioglu CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1 J. Biol. Chem. 273 1998 31853 31859
12. J.D. Debes, L.J. Schmidt, H. Huang, and D.J. Tindall p300 mediates interleukin-6-dependent transactivation of the androgen receptor Cancer Res. 62 2002 5632 5636
13. A. Hobisch, I.E. Eder, T. Putz, W. Horninger, G. Bartsch, H. Klocker, and Z. Culig Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor Cancer Res. 58 1998 4640 4645
14. D. Giri, M. Ozen, and M. Ittmann Interleukin-6 is an autocrine growth factor in human prostate cancer Am. J. Pathol. 159 2001 159 165
15. D.A. Twillie, M.A. Eisenberger, M.A. Carducci, W.-S. Hseih, W.Y. Kim, and J.W. Simons Interleukin-6: a candidate mediator of human prostate cancer morbidity Urology 45 1995 542 549
16. T.D. Chung, J.J. Yu, M.T. Spiotto, M. Bartkowski, and J.W. Simons Characterization of the role of IL-6 in the progression of prostate cancer Prostate 38 1999 199 207
17. T. Bellido, R.L. Jilka, B.F. Boyce, G. Girasole, H. Broxmeyer, S.A. Dalrymple, R. Murray, and S.C. Manolagas Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens J. Clin. Invest. 95 1995 2886 2895
18. U. Santhanam, A. Ray, and P.B. Sehgal Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product Proc. Natl. Acad. Sci. U.S.A. 88 1991 7605 7609
19. A. Hobisch, R. Ramoner, D. Fuchs, S. Godoy-Tundidor, G. Bartsch, H. Klocker, and Z. Culig Prostate cancer cells (LNCaP) generated after long-term interleukin-6 treatment express interleukin-6 and acquire an interleukin-6-partially resistant phenotype Clin. Cancer Res. 7 2001 2941 2948
20. H. Steiner, S. Godoy-Tundidor, H. Rogatsch, A.P. Berger, D. Fuchs, B. Comuzzi, G. Bartsch, A. Hobisch, and Z. Culig Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway Am. J. Pathol. 162 2003 655 663
21. D.L. Lin, M.C. Whitney, and E.T. Keller Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression Clin. Cancer Res. 7 2001 1773 1781
22. T. Ueda, N.R. Mawji, N. Bruchovsky, and M.D. Sadar Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells J. Biol. Chem. 277 2002 38087 38094
23. B. Comuzzi, L. Lambrinidis, H. Rogatsch, S. Godoy-Tundidor, N. Knezevic, I. Krhen, Z. Marekovic, G. Bartsch, H. Klocker, A. Hobisch, and Z. Culig The transciptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function Am. J. Pathol. 162 2003 233 241
24. R. Joyce, M.A. Fenton, P. Rode, M. Constantine, L. Gaynes, G. Kolvenbag, W. DeWolf, S. Balk, M.E. Taplin, and G.J. Bubley High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy J. Urol. 159 1998 149 153
25. M.E. Brady, D.M. Ozanne, L. Gaughan, I. Waite, S. Cook, and D.E. Neal Tip60 is a nuclear hormone receptor coactivator J. Biol. Chem. 274 1999 17599 17604
26. K. Halkidou, V.J. Gnanapragasam, P.B. Mehta, I.R. Logan, M.E. Brady, S. Cook, H.Y. Leung, D.E. Neal, and C.N. Robson Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development Oncogene 22 2003 2466 2477
27. S. Yeh, and C. Chang Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells Proc. Natl. Acad. Sci. U.S.A. 93 1996 5517 5521
28. H. Miyamoto, S. Yeh, G. Wilding, and C. Chang Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells Proc. Natl. Acad. Sci. U.S.A. 95 1998 7379 7384
29. S. Yeh, H. Miyamoto, H. Shima, and C. Chang From estrogen to androgen receptors: a new pathway for sex hormones in prostate Proc. Natl. Acad. Sci. U.S.A. 95 1998 5527 5532
30. H. Miyamoto, S. Yeh, H. Lardy, E. Messing, and C. Chang Delta 5-androstanediol is a natural hormone with androgenic activity in human prostate cancer cells Proc. Natl. Acad. Sci. U.S.A. 95 1998 11083 11088
31. S. Yeh, H.K. Lin, H.Y. Kang, T.H. Thin, M.F. Lin, and C. Chang From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proc. Natl. Acad. Sci. U.S.A. 96 1999 5458 5463
32. I. Leav, K.M. Lau, J.Y. Adams, J.E. McNeal, M.E. Taplin, J. Wang, H. Singh, and S.M. Ho Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma Am. J. Pathol. 159 2001 79 92
33. C.W. Gregory, K.G. Hamil, D. Kim, S.H. Hall, T.G. Pretlow, J.L. Mohler, and F.S. French Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes Cancer Res. 58 1998 5718 5724
34. S. Tekur, K.M. Lau, J. Long, K. Burnstein, and S.M. Ho Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids Mol. Carcinog. 30 2001 1 13
35. S.H. Mitchell, W. Zhu, and C.Y. Young Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells Cancer Res. 59 1999 5892 5899
36. P. Li, X. Yu, K. Ge, J. Melamed, R.G. Roeder, and Z. Wang Heterogenous expression and functions of androgen receptor co-factors in primary prostate cancer Am. J. Pathol. 161 2002 1467 1474
37. G. Han, B.A. Foster, S. Mistry, G. Buchanan, J.M. Harris, W.D. Tilley, and N.M. Greenberg Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in authochthonous prostate cancer J. Biol. Chem. 276 2001 11204 11213
38. P. Alen, F. Claessens, E. Schoenemakers, J.V. Swinnen, G. Vehoeven, W. Rombauts, and B. Peeters Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1 alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform Mol. Endocrinol. 13 1999 117 128
39. T. Gao, K. Brantley, E. Bolu, and M.J. McPhaul RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays Mol. Endocrinol. 13 1999 1645 1656
40. N. Fujimoto, S. Yeh, H.Y. Kang, S. Inui, H.C. Chang, A. Mizokami, and C. Chang Cloning and characterization of androgen receptor coactivator, ARA 55, in human prostate J. Biol. Chem. 274 1999 8316 8321
41. H.Y. Kang, S. Yeh, N. Fujimoto, and C. Chang Cloning and characterization of human prostate coactivator ARA 54, a novel protein that associates with the androgen receptor J. Biol. Chem. 274 1999 8570 8576
42. H. Miyamoto, M. Rahman, H. Takatera, H.Y. Kang, S. Yeh, H.C. Chang, K. Nishimura, N. Fujimoto, and C. Chang A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth J. Biol. Chem. 277 2002 4609 4617
43. P.W. Hsiao, and C. Chang Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells J. Biol. Chem. 274 1999 22372 22379
44. X. Wang, S. Yeh, G. Wu, C.L. Hsu, L. Wang, T. Chiang, Y. Yang, Y. Guo, and C. Chang Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells J. Biol. Chem. 276 2001 40417 40423
45. K. Hofman, J.V. Swinnen, G. Verhoeven, and W. Heyns E2F activity is biphasically regulated by androgens in LNCaP cells Biochem. Biophys. Res. Commun. 283 2001 97 101
46. S. Yeh, H. Miyamoto, K. Nishimura, H. Kang, J. Ludlow, P. Hsiao, C. Wang, C. Su, and C. Chang Retinoblastoma, a tumor suppressor is a coactivator for the androgen receptor in human prostate cancer DU-145 cells Biochem. Biophys. Res. Commun. 248 1998 361 367
47. S. Yeh, Y.C. Hu, M. Rahman, H.K. Lin, C.L. Hsu, H.J. Ting, H.Y. Kang, and C. Chang Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells Proc. Natl. Acad. Sci. U.S.A. 97 2000 11256 11261
48. A. Yamamoto, Y. Hashimoto, K. Kohri, E. Ogata, S. Kato, K. Ikeda, and M. Nakanishi Cyclin E as a coactivator of the androgen receptor J. Cell. Biol. 150 2000 873 880
49. E.S.W. Ngan, Y. Hashimoto, Z.-Q. Ma, M.J. Tsai, and S.Y. Tsai Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer Oncogene 22 2002 734 739
50. H.Y. Kang, H.K. Lin, Y.C. Hu, S. Yeh, K.E. Huang, and C. Chang From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells Proc. Natl. Acad. Sci. U.S.A. 98 2001 3018 3023
51. S.A. Hayes, M. Zarnegar, M. Sharma, F. Yang, D.M. Peehl, P. ten Dijke, and Z. Sun SMAD3 represses androgen receptor-mediated transcription Cancer Res. 61 2001 2112 2118
52. K. Nishimura, H.J. Ting, Y. Harada, T. Tokizane, N. Nonomura, H.Y. Kang, H.C. Chang, S. Yeh, H. Miyamoto, M. Shin, K. Aozasa, A. Okuyama, and C. Chang Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator Cancer Res. 63 2003 4888 4894
53. B.A. Froesch, S. Takayama, and J.C. Reed BAG-1L protein enhances androgen receptor function J. Biol. Chem. 283 1998 11660 11666
54. J.M. Muller, E. Metzger, H. Greschik, A.K. Bosserhoff, L. Mercep, R. Buettner, and R. Schule The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus EMBO J. 21 2002 736 748
55. C.I. Truica, S. Byers, and E.P. Gelmann Beta-catenin affects androgen receptor transcriptional activity and ligand specificity Cancer Res. 60 2000 4709 4713